SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who wrote (52)5/31/2000 3:54:00 PM
From: tommysdad  Read Replies (2) of 598
 
The key question is: why? Why are they doing this? They are absolutely flush with cash from their IPO and their secondary, so they go partner up? JT is bringing nothing but cash to the table, gets half of any products, and has a buy-back option.

What's in it for TLRK? They could have easily funded this themselves and owned it all. (Before someone responds with a "dilution of risk" answer, I submit that a company that takes an irreversible tubulin inhibitor into the clinic is quite comfortable with risk).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News